O'Connor Alternative Investments’s Gilead Sciences GILD Stock Holding History

O'Connor Alternative Investments’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.49M	Buy	+11,800	New	+$1.55M	0.11%	92

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

O'Connor Alternative Investments's GILD Position: Q2 2026 in Review

O'Connor Alternative Investments opened a new position in Gilead Sciences (GILD) in Q2 2026: 11,800 shares worth $1.49M. The stake represents 0.11% of the portfolio and ranks #92 among its holdings.

2,169 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

O'Connor Alternative Investments held 11,800 shares of Gilead Sciences worth $1.49M as of Q2 2026.
Gilead Sciences was a new O'Connor Alternative Investments position in Q2 2026.
Gilead Sciences made up 0.11% of O'Connor Alternative Investments's portfolio in Q2 2026, its #92 holding.
2,169 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on O'Connor Alternative Investments's 13F filing for Q2 2026, filed 14 Aug 2026.